Technology
New On Robinhood
Health

Orchard Therapeutics

$17.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.95 (5.85%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ORTX and other stocks, options, ETFs, and crypto commission-free!

About

Orchard Therapeutics plc American Depositary Shares, also called Orchard Therapeutics, is a biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of gene therapies. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Read More Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). It operates through the United Kingdom and United States geographical segments. The company was founded in August 2018 and is headquartered in London, the United Kingdom.

Employees
53
Headquarters
London, Greater London
Founded
2018
Market Cap
1.38B
Price-Earnings Ratio
Dividend Yield
Average Volume
104.42K
High Today
$17.28
Low Today
$16.32
Open Price
$16.80
Volume
59.51K
52 Week High
$19.24
52 Week Low
$8.65

Collections

Technology
New On Robinhood
Health
Pharmaceutical
Therapy
Biopharmaceutical
Gene Therapies
2018 IPO

Earnings

-$3.79
-$3.37
-$2.95
-$2.53
Q4 2018
Estimated
-$3.16 per share
Actual
Available Mar 21, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.